Literature DB >> 6091844

Kynurenic acid as an antagonist of hippocampal excitatory transmission.

M B Robinson, K D Anderson, J F Koerner.   

Abstract

Kynurenate, an endogenous tryptophan metabolite, was bath-applied to hippocampal slices while recording extracellular synaptic field potentials. Kynurenate antagonized the medial and lateral entorhinal projections to dentate granule cells, the Schaffer collateral projections to CA1 pyramidal cells, and inputs to the CA3 stratum radiatum of regio inferior with similar potencies. Concentration-response curves for these pathways paralleled theoretical antagonist curves with a Hill coefficient of 1, and the KdS were in the range of 130-400 microM. Projections to the stratum lucidum of regio inferior were much less sensitive to kynurenate. Inputs to CA3 pyramidal cells showed varying sensitivities to kynurenate, L-2-amino-4-phosphonobutanoic acid (L-APB), and (-)-baclofen depending on the placements of the stimulating and recording electrodes. When both electrodes were located in area CA3, outside the hilus of area dentata, all responses were insensitive to inhibition by L-APB. Under these conditions, responses recorded within the stratum radiatum were sensitive to inhibition by kynurenate and baclofen, while responses recorded within the stratum lucidum were insensitive to these drugs. When the stimulating electrode was placed within the hilus of area dentata, variable patterns of sensitivity to APB, baclofen, and kynurenate were observed from recording electrodes in area CA3. These results suggest that stimulation in the hilus, while recording in the stratum lucidum, produces responses that show composite effects resulting both from direct stimulation of mossy fibers and from stimulation of neuronal elements in the hilus which produce outputs to mossy fibers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091844     DOI: 10.1016/0006-8993(84)91015-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Tryptophan therapy for non-ketotic hyperglycinaemia.

Authors:  F Inoue; S Matsuo; H Yoshioka; Y Takeuchi; H Yamanaka; N Kodo; A Kinugasa; T Sawada
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  The effects of Ca2+, Mg2+ and kynurenate on primary afferent synaptic potentials evoked in cat spinal cord neurones in vivo.

Authors:  B Walmsley; M J Nicol
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

3.  Glutamate receptors of ganglion cells in the rabbit retina: evidence for glutamate as a bipolar cell transmitter.

Authors:  S C Massey; R F Miller
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

4.  Synaptic potentials in rat locus coeruleus neurones.

Authors:  E Cherubini; R A North; J T Williams
Journal:  J Physiol       Date:  1988-12       Impact factor: 5.182

5.  Excitatory amino acids in synaptic excitation of rat striatal neurones in vitro.

Authors:  E Cherubini; P L Herrling; L Lanfumey; P Stanzione
Journal:  J Physiol       Date:  1988-06       Impact factor: 5.182

6.  BDNF-induced presynaptic facilitation of GABAergic transmission in the hippocampus of young adults is dependent of TrkB and adenosine A2A receptors.

Authors:  Mariana Colino-Oliveira; Diogo M Rombo; Raquel B Dias; Joaquim A Ribeiro; Ana M Sebastião
Journal:  Purinergic Signal       Date:  2016-02-20       Impact factor: 3.765

7.  Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals.

Authors:  J T Porter; K D McCarthy
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

Review 8.  Glutamate in the mammalian CNS.

Authors:  S Sahai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

9.  Actions of excitatory amino acid antagonists on geniculo-cortical transmission in the cat's visual cortex.

Authors:  K Hagihara; T Tsumoto; H Sato; Y Hata
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.